A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lymphogranuloma Venereum (LGV) Differentiation Antibody Panel, MIF
MessageFor Specimen Integrity during Extreme Weather see the “Lockbox Usage in Extreme Weather” document at the top of this page.
Test Code
LGVDFF
CPT Codes
86631 (x8), 86632 (x4)
Includes
C. trachomatis L1 Ab (IgG, IgA, IgM)
C. trachomatis D-K Ab (IgG, IgA, IgM)
C. pneumoniae Ab (IgG, IgA, IgM)
C. psittaci Ab (IgG, IgA, IgM)
C. trachomatis D-K Ab (IgG, IgA, IgM)
C. pneumoniae Ab (IgG, IgA, IgM)
C. psittaci Ab (IgG, IgA, IgM)
Preferred Specimen
1 mL serum
Minimum Volume
0.2 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric
Methodology
Micro-Immunofluorescence (MIF)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Tues-Sat; Report available: 2-4 days
Reference Range
See Laboratory Report
Clinical Significance
Lymphogranuloma venerum (LGV) is a clinical syndrome caused by infection with C. trachomatis which typically includes genital bubonic disease. The serologic detection of C. trachomatis infection is complicated by the presence of crossreactive antibody to other Chlamydia species or nonspecific stimulation of anti-Chlamydia Ab. To differentiate C. trachomatis infection from other Chlamydia species, a panel of Chlamydia is tested for the determination of specific antibody titers.
Performing Laboratory
Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
33608 Ortega Highway |
San Juan Capistrano, CA 92675-2042 |
Last Updated: November 24, 2021